Skip to search formSkip to main contentSkip to account menu

Maxillary left first premolar implant

Known as: 12i 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
Design, synthesis, assessment, and molecular docking of novel pyrrolopyrimidine (7-deazapurine) derivatives as non-nucleoside hepatitis C virus NS5B polymerase inhibitors.
2012
2012
Linker-based hemisuccinate derivatives of artemisinin: synthesis and antimalarial assessment against multidrug-resistant Plasmodium yoelii nigeriensis in mice.
Artesunic acid 5, the hemisuccinate derivative of dihydroartemisinin 2, is the only clinically useful water-soluble derivative of… 
2012
2012
Molecular Subtyping of Treponema pallidum during a Local Syphilis Epidemic in Men Who Have Sex with Men in Melbourne, Australia
ABSTRACT Treponema pallidum is the causative agent of syphilis, a sexually transmitted infection of significant public health… 
2010
2010
On the Feasibility of Verification of 3D Dosimetry Near Brachytherapy Sources Using PRESAGE/Optical-CT
The feasibility of using the PRESAGE/Optical-CT system for 3D dosimetry verification around a brachytherapy source is… 
2010
2010
Synthesis and SOD activity of manganese complexes of substituted pyridino pentaaza macrocycles that contain axial auxiliary.
2009
2009
Synthesis of novel bioactive derivatives of 3-(4-chlorophenyl)-2-hydrazino-5,6,7,8-tetrahydrobenzo(b)thieno[2,3-d]pyrimidine-4(3H)-ones.
2007
2007
Phenylpiperidine-benzoxazinones as urotensin-II receptor antagonists: synthesis, SAR, and in vivo assessment.
2006
2006
Crystal-chemical investigation of kalsilite from San Venanzo, Italy, using single-crystal X-ray diffraction and Raman spectroscopy
2001
2001
Dosimetry characteristics of the Plus and 12i Gammamed PDR 192Ir sources.
In this study a complete set of dosimetric data for the Plus and 12i Gammamed PDR (pulsed dose rate) 192Ir sources is presented… 
1997
1997
[Salvage therapy of advanced squamous cell carcinoma of the mouth cavity and oropharynx. Results of interstitial high-dose-rate brachytherapy combined with ablative tumor surgery].
PURPOSE The clinical effect of high-dose-rate (HDR) interstitial brachytherapy combined with tumor resection was investigated in… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)